- Lung Cancers
- Contact us info@ultraspecialisti.com
- Owned by: Ultraspecialisti S.r.l.
Menu
Diagnostic tests, histological classification, liquid biopsy and genomic tests
Chest X-Ray (CXR), Computerized Axial Tomography (CAT) of the Thorax, Positron Emission Tomography (PET), Histological and Cytological Diagnosis, Genomic Test, Liquid Biopsy, Bone Scintigraphy, CT or MRI of the brain with contrast medium
Today, it is no longer sufficient to know whether the disease is a small cell or non-small cell tumor, but whether it is a squamous cell carcinoma, an adenocarcinoma, or a large cell or small-cell neuroendocrine tumor.
To assess the possibility of using personalized medicine (or precision medicine) on a lung cancer patient, it may be useful to use genomic tests that would recognize clinically relevant DNA alterations.
A liquid biopsy is performed using a simple blood sample that is analyzed to identify molecular markers. It is a much less invasive procedure than the ‘traditional’ biopsy.
